Navigation Links
Medco CEO to Present at the Sanford C. Bernstein & Co., LLC 26th Annual Strategic Decisions Conference 2010
Date:6/1/2010

FRANKLIN LAKES, N.J., June 1 /PRNewswire-FirstCall/ -- David B. Snow Jr., chairman and CEO, of Medco Health Solutions, Inc. (NYSE: MHS), is scheduled to address the Sanford C. Bernstein & Co., LLC 26th Annual Strategic Decisions Conference 2010 in New York on Wednesday, June 2, 2010.

The presentation at the Waldorf Astoria, New York, will begin at 3 p.m. EDTRichard J. Rubino, Medco's chief financial officer, is also scheduled to attend.

The presentation may be heard live via a simulcast link and the accompanying slides will be available at www.medco.com/investor.  Real Player or Windows Media Player is required to listen to the webcast.  Free downloads of both players are available at the webcast site.  The webcast will be available for replay for one month following the presentation.

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2009 revenues of nearly $60 billion, Medco ranks 35th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies. 

For more information, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medco to Present at the 2010 Citi Investment Research Global Health Care Conference
2. Medco Donates $125,000 to Red Cross for Flood Relief in Tennessee and Other Affected Areas
3. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
4. Medco Announces Webcast for Annual Meeting of Shareholders
5. Medco to Present at Upcoming Investor Conferences
6. Medco to Present at the Deutsche Bank 35th Annual Health Care Conference
7. Medco, Mayo Clinic Study Reveals Using a Simple Genetic Test Reduces Hospitalization Rates by Nearly a Third for Patients on Widely Prescribed Blood Thinner
8. NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
9. Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
10. Medco to Present at Upcoming Investor Conferences
11. Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... ALTO, Calif. , June 9, 2017 ... device company focused on the design, manufacture, sale and ... the market on the progress of its commercial roll-out ... is now available in more than one hundred (100) ... AeroForm offers a needle-free alternative for ...
(Date:6/7/2017)... 7, 2017 Endo International plc (NASDAQ: ... the Hon. Joseph R. Goodwin , U.S. District ... West Virginia , entered a case management order ... System Products Liability Litigation (the "MDL") that includes a ... provide expert disclosures on specific causation within one hundred ...
(Date:6/3/2017)... 3, 2017  Eli Lilly and Company (NYSE: ... from the Phase 3 MONARCH 2 study showed ... inhibitor, in combination with fulvestrant, significantly improved progression-free ... in women with hormone-receptor-positive (HR+), human epidermal growth ... have relapsed or progressed after endocrine therapy (median ...
Breaking Medicine Technology:
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance and ... to clients in southern Montana, is announcing a focused charity effort to gather ... outreach programs offered by Zoo Montana provide students with current knowledge on the ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... servicing communities throughout the greater Cincinnati metropolitan area, is teaming up with the ... for families with children receiving treatment in nearby hospitals. , Ronald McDonald House ...
(Date:6/27/2017)... , ... June 27, 2017 , ... DrugDev ... is whether they can trust the sponsor to pay them correctly and on time. ... and CROs establish payment strategies that encourage sites to work on their studies. , ...
(Date:6/27/2017)... MA (PRWEB) , ... June 27, 2017 , ... The ... Senate bill to repeal and replace the 2010 Patient Protection and Affordable Care Act ... compared with what would be expected under current law. , More than 20 million ...
(Date:6/27/2017)... ... June 27, 2017 , ... A January 18th article on medGadget ... $6.81 billion by the year 2024 according to a new report. The article also ... made from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center ...
Breaking Medicine News(10 mins):